DHG Pharmaceutical JSC (HOSE: DHG)

DHG Pharmaceutical JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	62,858	62,858	94,134	34,018	43,374	73,054
Short-Term Investments	2,745,000	2,745,000	1,960,000	2,265,000	1,975,000	1,974,000
Cash & Short-Term Investments	2,807,858	2,807,858	2,054,134	2,299,018	2,018,374	2,047,054
Cash Growth	36.69%	36.69%	-10.65%	13.90%	-1.40%	20.53%
Accounts Receivable	523,860	523,860	528,859	279,862	315,113	363,249
Other Receivables	88,560	88,560	107,787	81,417	77,757	63,328
Receivables	612,678	612,678	636,904	361,537	393,141	426,958
Inventory	1,115,429	1,115,429	1,534,636	1,250,834	1,072,606	826,585
Prepaid Expenses	10,860	10,860	8,007	10,201	5,827	3,327
Other Current Assets	57,179	57,179	408,511	297,183	237,346	176,875
Total Current Assets	4,604,004	4,604,004	4,642,193	4,218,772	3,727,293	3,480,800
Property, Plant & Equipment	1,066,375	1,066,375	1,187,884	678,171	631,658	705,687
Long-Term Investments	4,438	4,438	4,175	3,860	4,578	4,388
Other Intangible Assets	178,106	178,106	181,861	201,812	205,780	210,084
Long-Term Deferred Tax Assets	18,340	18,340	16,872	15,845	17,535	16,068
Other Long-Term Assets	87,982	87,982	77,489	49,726	30,822	30,477
Total Assets	5,959,243	5,959,243	6,110,474	5,168,187	4,617,666	4,447,503
Accounts Payable	167,297	167,297	217,976	364,379	201,220	252,271
Accrued Expenses	363,725	363,725	313,579	227,615	257,956	255,737
Short-Term Debt	649,914	649,914	572,165	114,723	207,391	212,272
Current Income Taxes Payable	-	-	17,365	12,678	4,208	14,624
Current Unearned Revenue	48,507	48,507	43,702	34,043	49,609	49,532
Other Current Liabilities	560,849	560,849	24,454	58,098	37,332	31,999
Total Current Liabilities	1,790,293	1,790,293	1,189,242	811,537	757,716	816,433
Other Long-Term Liabilities	74,195	74,195	68,298	65,113	66,807	63,031
Total Liabilities	1,864,488	1,864,488	1,257,540	876,650	824,523	879,464
Common Stock	1,307,461	1,307,461	1,307,461	1,307,461	1,307,461	1,307,461
Additional Paid-In Capital	6,779	6,779	6,779	6,779	6,779	6,779
Retained Earnings	2,780,515	2,780,515	3,538,695	2,977,297	2,475,770	2,249,731
Total Common Equity	4,094,755	4,094,755	4,852,935	4,291,537	3,790,010	3,563,971
Minority Interest	-	-	-	-	3,134	4,068
Shareholders' Equity	4,094,755	4,094,755	4,852,935	4,291,537	3,793,144	3,568,039
Total Liabilities & Equity	5,959,243	5,959,243	6,110,474	5,168,187	4,617,666	4,447,503
Total Debt	649,914	649,914	572,165	114,723	207,391	212,272
Net Cash (Debt)	2,157,944	2,157,944	1,481,969	2,184,294	1,810,982	1,834,783
Net Cash Growth	45.61%	45.61%	-32.15%	20.61%	-1.30%	27.98%
Net Cash Per Share	16504.84	16504.84	11334.72	16706.39	13851.14	14033.18
Filing Date Shares Outstanding	130.75	130.75	130.75	130.75	130.75	130.75
Total Common Shares Outstanding	130.75	130.75	130.75	130.75	130.75	130.75
Working Capital	2,813,711	2,813,711	3,452,951	3,407,236	2,969,577	2,664,367
Book Value Per Share	31318.38	31318.38	37117.25	32823.45	28987.56	27258.72
Tangible Book Value	3,916,649	3,916,649	4,671,074	4,089,725	3,584,230	3,353,886
Tangible Book Value Per Share	29956.15	29956.15	35726.31	31279.91	27413.67	25651.91
Buildings	-	-	575,489	578,613	528,464	528,464
Machinery	-	-	1,029,566	903,189	866,975	875,218
Construction In Progress	48,614	48,614	553,594	92,596	69,508	66,473

Source: S&P Capital IQ. Standard template. Financial Sources.